• Leveljump Healthcare Corp. (JUMP) will not be proceeding with its purchase of Telehospital Corp.
  • The transaction was originally scheduled for the end of June, 2022
  • Leveljump Healthcare is a leader in business-to-business (B2B) telehealth solutions
  • LevelJump Healthcare Corp. (TSXV:JUMP) opened trading at C$0.075

Leveljump Healthcare Corp. (JUMP) will not be proceeding with its previously announced purchase of Telehospital Corp.

The transaction was initially scheduled to close at the end of June 2022, but the vendors demanded certain last-minute adjustments, which Leveljump did not accept.

Leveljump continues looking for acquisitions to complement and expand its existing operations.

Leveljump Healthcare is a leader in business-to-business (B2B) telehealth solutions.

LevelJump Healthcare Corp. (TSXV:JUMP) opened trading at C$0.075.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.